Back
Speaker illustration

Doctor Kentaro Ejiri

Okayama University Hospital, Okayama (Japan)

Member of:

European Society of Cardiology

RESEARCH INTERESTS: General cardiovascular disease (preventive cardiology and prediction) My research focuses on making progress in clinical practice by the validation of the safety and efficacy of new therapeutic concept through clinical study, specifically on cardiovascular disease (preventive cardiology and prediction). EDUCATION: MD, March 2007 – KOCHI MEDICAL SCHOOL, Kochi, Japan PhD in Medicine (Cardiovascular Medicine), March 2019 – Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan Postdoctoral Fellow, Johns Hopkins Bloomberg School of Public Health at Baltimore, USA, October 2021–2023 PROFESSIONAL EXPERIENCE: OKAYAMA SAISEIKAI HOSPITAL at Okayama, April 2007 Department of Cardiology, HIROSHIMA CITY HOSPITAL at Hiroshima, April 2009 Department of Cardiology, OKAYAMA MEDICAL CENTER at Okayama, April 2011 Department of Cardiovascular Medicine, OKAYAMA UNIVERSITY HOSPITAL at Okayama, April 2020

Presentations

Associations of segment-specific pulse wave velocity with vascular calcification: The Atherosclerosis Risk in Communities (ARIC) Study

Event: ESC Congress 2022

Topic: Coronary Calcium

Session: Coronary calcium: new aspects in quantification and use in clinical routine

Access
Like
Thumbnail

Impact of coronary stent length on periprocedural myocardial injury after percutaneous coronary intervention for stable coronary artery disease: from the RINC randomized controlled trial data

Event: ESC Congress 2017

Topic: PCI: procedural complications

Session: PCI - Procedure complications

Access
Like
Thumbnail

The effect of remote ischemic preconditioning for myocardial injury following percutaneous coronary intervention in stable angina patients with complex coronary lesion: results of the RINC trial

Event: ESC Congress 2016

Topic: PCI: primary PCI / patient subsets

Session: PCI complications

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources